Trump’s plan to distribute prescription cards remains up in air

President Donald Trump made a surprise announcement on September 24, revealing that 33 million Medicare recipients would, in the coming weeks, receive coupons they can use to pay for prescription drugs. But uncertainty remains.

According to a blog post from The Hill, Trump “made no effort” to hide the fact that he considers the move a means of currying favor with senior citizens—who comprise a key voting bloc—ahead of the Presidential election.

The White House has provided no clear explanation of where the nearly $7 billion needed to provide the coupons would come from. Blog writer Peter Sullivan quotes a “White House official” as noting, when the announcement was made, that spending on the coupons would be offset by a program to lower drug prices by tying them to lower prices in other nations.

“But that plan, while it has been proposed, has not gone into effect yet, meaning that there are currently no savings from it,” Sullivan writes.

On September 25, The Wall Street Journal reported that the funds would come from the Medicare Trust Fund, an idea that reportedly sparked a rebuke by Speaker Nancy Pelosi (D-Calif.). Pelosi said Trump’s initiative to distribute the coupons is evidence of his desire to “steal from the Medicare Trust Fund for a desperately transparent political gimmick.”

That same day, on a call with reporters about actions to lower drug prices, Department of Health and Human Services officials provided no details when asked about funding for the program. They noted that such information would be forthcoming from the White House in the future.

Moreover, the move reportedly is questionable from a legal standpoint. Congress has yet to authorize the funds for the coupons. Some healthcare experts, Sullivan reports, believe Trump’s move would be an “unprecedented use” of the Medicare program for political gain ahead of the election.

Read the blog here. Click here for Pelosi’s statement.

So far, GOP leaders have not mounted a concerted campaign in support of the President’s coupon plan.

Julie Ritzer Ross,

Contributor

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup